Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin- inactivated RSV vaccine

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 8971-8975

  Tripp, Ralph A ^a,b   Anderson, Larry J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE FREQUENCY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INACTIVATION;

EID: 0031658926     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.8971-8975.1998     Document Type: Article

References (41)

1. Cannon, M. J., P. J. Openshaw, and B. A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
2. Chin, J., R. L. Magoffin, L. A. Shearer, J. H. Schieble, and E. H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
3. Ciupitu, A. M., M. Petersson, C. L. O'Donnell, K. Williams, S. Jindal, R. Kiessling, and R. M. Welsh. 1998. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J. Exp. Med. 187(5):685-691.
4. Cole, G. A., Y. Tao, T. L. Hogg, K. W. Ryan, and D. L. Woodland. 1995. Binding motifs predict major histocompatibility complex class II-restricted epitopes in the Sendai virus M protein. J. Virol. 69:8057-8060.
5. Connors, M., P. L. Collins, C.-Y. Firestone, and B. R. Murphy. 1991. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 65:1634-1637.
6. Connors, M., N. A. Giese, A. B. Kulkarni, C.-Y. Firestone, H. C. Morse III, and B. R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:5321-5325.
7. + T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. J. Virol. 66:1277-1281.
8. + T cells. J. Virol. 66:7444-7451.
9. Corvaisier, C., G. Guillemin, C. Bourgeois, J. B. Bour, E. Kohli, and P. Pothier. 1993. Identification of T-cell epitopes adjacent to neutralizing antigenic domains on the fusion protein of respiratory syncytial virus. Res. Virol. 144:141-150.
10. Dhib-Jalbut, S., and S. Jacobson. 1994. Cytotoxic T cells in paramyxovirus infection in humans. Curr. Top. Microbiol. Immunol. 189:109-121.
11. Doherty, P. C. 1996. Cytotoxic T cell effector and memory function in viral immunity. Curr. Top. Microbiol. Immunol. 206:1-14.
12. + T-cell memory to viruses. Curr. Opin. Immunol. 6:545-552.
13. + T cell memory. Immunol. Rev. 150:23-44.
14. + T cells. Virology 210:179-185.
15. Fulginiti, V. A., J. J. Eller, O. F. Sieber, J. W. Joyner, M. Minamitani, and G. Meiklejohn. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
16. Graham, B. S. 1996. Immunological determinants of disease caused by respiratory syncytial virus [see comments]. Trends Microbiol. 4:290-293.
17. Graham, B. S., G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil, and D. G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
18. Graham, B, S., L. A. Bunton, P. F. Wright, and D. T. Kamm. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88:1026-1033.
19. + cytotoxic T cells against mouse hepatitis virus A59. Immunology 84:521-527.
20. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J. Immunol. 150:5494-5500.
21. + T ceils control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27(12):3341-3349.
22. Institute of Medicine. 1985. New vaccine development: establishing priorities, diseases of importance in the United States. National Academy Press, Washington, D.C.
23. Institute of Medicine. 1986. New vaccine development: establishing priorities, diseases of importance in developing countries. National Academy Press, Washington, D.C.
24. Kapikian, A. Z., R. H. Mitchell, R. M. Chanock, R. A. Shvedoff, and C. E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
25. Kim, H. W., J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen, and R. H. Parrott. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
26. + lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. J. Virol. 67:1044-1049.
27. Mbiguino, A., and J. Menezes. 1991. Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients. J. Virol. Methods 31:161-170.
28. Murphy, B. R., S. L. Hall, A. B. Kulkarni, J. E. Crowe, Jr., P. L. Collins, M. Connors, R. A. Karron, and R. M. Chanock. 1994. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:13-36.
29. Nicholas, J. A., K. L. Rubino, M. E. Levely, E. G. Adams, and P. L. Collins. 1990. Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. J. Virol. 64:4232-4241.
30. Openshaw, P. J. 1995. Immunity and immunopathology to respiratory syncytial virus. The mouse model. Am. J. Respir. Crit. Care Med. 152:S59-S62.
31. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J. Exp. Med. 186(3):421-432.
32. Tang, Y. W., and B. S. Graham. 1995. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:734-738.
33. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
34. + CTL against influenza-sensitized autologous splenocytes. Immunol. Lett. 46:67-73.
35. + memory T cells. J. Immunol. 154:5870-5875.
36. + T cells in respiratory virus infections. J. Immunol. 154:6013-6021.
37. + T cell response in mice homozygous for disruption of the H-21Ab gene. J. Immunol. 155:2955-2959.
38. UytdeHaag, F. G., R. S. van Binnendijk, M. J. Renter, and A. D. Osterhaus. 1994. Cytotoxic T lymphocyte responses against measles virus. Curr. Top. Microbiol. Immunol. 189:151-167.
39. van Binnendijk, R. S., J. P. Versteeg-van Oosten, M. C. Poelen, H. F. Brugghe, P. Hoogerhout, A. D. Osterhaus, and F. G. Uytdehaag. 1993. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J. Virol. 67:2276-2284.
40. Waris, M. E., C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson. 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:2852-2860.
41. Welliver, R. C., D. A. Tristram, K. Batt, M. Sun, D. Hogerman, and S. Hildreth. 1994. Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine. J. Infect. Dis. 170:425-428.